FI934933A0 - Foerfarande foer framstaellning av ergolinderivat - Google Patents

Foerfarande foer framstaellning av ergolinderivat

Info

Publication number
FI934933A0
FI934933A0 FI934933A FI934933A FI934933A0 FI 934933 A0 FI934933 A0 FI 934933A0 FI 934933 A FI934933 A FI 934933A FI 934933 A FI934933 A FI 934933A FI 934933 A0 FI934933 A0 FI 934933A0
Authority
FI
Finland
Prior art keywords
ergolinderivat
formula
foerfarande foer
foer framstaellning
image
Prior art date
Application number
FI934933A
Other languages
English (en)
Other versions
FI113473B (fi
FI934933A (fi
Inventor
Ilaria Candiani
Walter Cabri
Angelo Bedeschi
Franco Zarini
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of FI934933A0 publication Critical patent/FI934933A0/fi
Publication of FI934933A publication Critical patent/FI934933A/fi
Application granted granted Critical
Publication of FI113473B publication Critical patent/FI113473B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06—Lysergic acid amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Psychology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Emergency Protection Circuit Devices (AREA)
  • Control Of Electric Motors In General (AREA)
FI934933A 1992-03-12 1993-11-08 Menetelmä ergoliinijohdannaisten valmistamiseksi FI113473B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9205439 1992-03-12
GB929205439A GB9205439D0 (en) 1992-03-12 1992-03-12 Process for the synthesis of ergoline derivatives
EP9300360 1993-02-15
PCT/EP1993/000360 WO1993018034A1 (en) 1992-03-12 1993-02-15 Process for the preparation of ergoline derivatives

Publications (3)

Publication Number Publication Date
FI934933A0 true FI934933A0 (fi) 1993-11-08
FI934933A FI934933A (fi) 1993-11-08
FI113473B FI113473B (fi) 2004-04-30

Family

ID=10712024

Family Applications (1)

Application Number Title Priority Date Filing Date
FI934933A FI113473B (fi) 1992-03-12 1993-11-08 Menetelmä ergoliinijohdannaisten valmistamiseksi

Country Status (25)

Country Link
US (1) US5382669A (fi)
EP (1) EP0593692B1 (fi)
JP (1) JP3339858B2 (fi)
KR (1) KR100274102B1 (fi)
CN (1) CN1038510C (fi)
AT (1) ATE180783T1 (fi)
AU (1) AU653099B2 (fi)
CA (1) CA2106371C (fi)
CZ (1) CZ281708B6 (fi)
DE (1) DE69325138D1 (fi)
FI (1) FI113473B (fi)
GB (1) GB9205439D0 (fi)
HU (1) HU210407B (fi)
IL (1) IL104973A (fi)
MX (1) MX9301297A (fi)
MY (1) MY109152A (fi)
NO (1) NO302754B1 (fi)
NZ (1) NZ249115A (fi)
PH (1) PH30138A (fi)
RU (1) RU2118323C1 (fi)
SK (1) SK279039B6 (fi)
TW (1) TW215089B (fi)
UA (1) UA26400C2 (fi)
WO (1) WO1993018034A1 (fi)
ZA (1) ZA931720B (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0007308D0 (en) 2000-03-24 2000-05-17 Pharmacia & Upjohn Spa Process for preparing crystalline form | of cabergoline
US6696568B2 (en) 2001-04-16 2004-02-24 Finetech Ltd. Process and intermediates for production of cabergoline and related compounds
IL155545A (en) * 2003-04-21 2009-12-24 Finetech Pharmaceutical Ltd Solvate form of cabergoline
HUP0400517A3 (en) * 2004-03-04 2006-05-29 Richter Gedeon Vegyeszet Process for producing cabergoline
GB0409785D0 (en) * 2004-04-30 2004-06-09 Resolution Chemicals Ltd Preparation of cabergoline
FR2877945A1 (fr) * 2004-11-18 2006-05-19 Archemis Sa Procede de la preparation de la cabergoline
EP1858894A1 (en) 2005-03-17 2007-11-28 Synthon Argentina S.A. Improved process for making cabergoline
GB0505965D0 (en) * 2005-03-23 2005-04-27 Resolution Chemicals Ltd Preparation of cabergoline
EP1925616A1 (en) * 2006-10-26 2008-05-28 LEK Pharmaceuticals D.D. Process for the preparation of crystal forms of cabergoline via stable solvates of cabergoline
US7939665B2 (en) * 2007-05-04 2011-05-10 Apotex Pharmachem Inc. Efficient process for the preparation of cabergoline and its intermediates
WO2014078857A1 (en) 2012-11-19 2014-05-22 Regents Of The University Of Minnesota Ergoline derivatives as dopamine receptor modulators

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2103603B (en) * 1981-08-11 1985-04-11 Erba Farmitalia Ergoline derivatives

Also Published As

Publication number Publication date
SK140193A3 (en) 1994-11-09
EP0593692B1 (en) 1999-06-02
HUT66712A (en) 1994-12-28
HU210407B (en) 1995-04-28
KR100274102B1 (ko) 2000-12-15
JP3339858B2 (ja) 2002-10-28
NO934077L (no) 1993-11-11
IL104973A (en) 1997-06-10
ZA931720B (en) 1993-11-01
CA2106371A1 (en) 1993-09-13
GB9205439D0 (en) 1992-04-22
MY109152A (en) 1996-12-31
TW215089B (fi) 1993-10-21
NZ249115A (en) 1995-04-27
AU653099B2 (en) 1994-09-15
CZ281708B6 (cs) 1996-12-11
FI113473B (fi) 2004-04-30
CZ271593A3 (en) 1994-04-13
WO1993018034A1 (en) 1993-09-16
MX9301297A (es) 1993-09-01
NO934077D0 (no) 1993-11-11
DE69325138D1 (de) 1999-07-08
AU3497493A (en) 1993-10-05
CN1076196A (zh) 1993-09-15
IL104973A0 (en) 1993-07-08
US5382669A (en) 1995-01-17
JPH06507648A (ja) 1994-09-01
RU2118323C1 (ru) 1998-08-27
EP0593692A1 (en) 1994-04-27
SK279039B6 (sk) 1998-05-06
NO302754B1 (no) 1998-04-20
PH30138A (en) 1997-01-21
CN1038510C (zh) 1998-05-27
FI934933A (fi) 1993-11-08
CA2106371C (en) 2003-09-23
ATE180783T1 (de) 1999-06-15
UA26400C2 (uk) 1999-08-30

Similar Documents

Publication Publication Date Title
ES2070660A1 (es) Un procedimiento para la preparacion de 2,5-damino-3-hidroxihexanos sustituidos, utiles como inhibidores de proteasas retrovirales.
IL106676A0 (en) Novel 7-(substituted)-8-(substituted-9-(substituted glycyl)amido)-6-demethyl-6-deoxytetracyclines
GB9822376D0 (en) Stabilizer compounds
MY113806A (en) Antiparasitic marcfortines and paraherquamides
CA2110693A1 (en) Amino acid derivative anticonvulsant
IL106673A (en) 7-(substituted)-9- £(substituted glycyl) amido|-6- demethyl-6- deoxytetracyclines
TW232013B (fi)
FI934933A0 (fi) Foerfarande foer framstaellning av ergolinderivat
NO20002676L (no) Androgene steroidforbindelser og en fremgangsmÕte for fremstilling og anvendelse av samme
UA7228A1 (uk) Спосіб одержання похідних n-(4-індолілпіперідиноалкіл )бензімідазолону або їх солей з кислотами
RU93058546A (ru) Способ получения производных эрголина, фармацевтическая композиция
NO940018D0 (no) Fremgangsmaate for fremstilling av svovelholdige imidazolderivater
GR1002598B (el) Παραγωγα επι-επιβατιδινης.
NO944238D0 (no) Fremgangsmåte for fremstilling av hydroxyalkancarboxylsyreamider
NO304688B1 (no) Fremgangsmaate for syntese av anvendelige mellomprodukter av substituerte imidazolforbindelser
HRP940174A2 (en) A chemical process for a synthesis of an antibacterial agent with an intermediate
HUP9801666A2 (hu) Eljárás ciano-formiát-észter-származék előállítására
ES8507520A1 (es) Un procedimiento para la preparacion de nuevos compuestos de b-lactama
ES2067388A1 (es) Procedimiento para la produccion de derivados de piroglutamato de configuracion 2,4-cis
TH13552EX (th) อนุพันธุ์ต่าง ๆ ของเบนโซฟิโนน

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: PHARMACIA & UPJOHN S.P.A.